Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 90 results found. Search for [ SII CEO Adar Poonawalla ]

Results 1 to 21 of 90
PB Jayakumar
February 24, 2021
Serum delivered 600,000 doses of Covishield vaccines from Pune to Accra in Ghana. The vaccines arrived on a flight from Mumbai, via Dubai, where the flight also collected a shipment of syringes from a Gavi-funded stockpile at UNICEF's regional supply hub


BusinessToday.In
February 21, 2021
Poonawalla appealed to countries and governments to be patient and assured that the coronavirus vaccine will be available to the rest of the world who are purchasing the AstraZeneca-Oxford doses from India


Joe C Mathew
February 19, 2021
Coronavirus vaccine: The Covid-19 vaccine candidate of Novavax is being studied in two ongoing pivotal Phase 3 clinical trials: in the United States and Mexico, as well as in the United Kingdom


BusinessToday.In
February 19, 2021
In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


BusinessToday.In
January 30, 2021
Serum Institute of India CEO Adar Poonawalla said the company's tie-up with American vaccine developer Novavax has published 'excellent efficacy results'


BusinessToday.In
January 29, 2021
Last year in September, Novavax had announced its deal with Serum Institute in order to produce 2 billion doses of COVID-19 vaccines


BusinessToday.In
January 21, 2021
SII Chairman & Managing Director Cyrus Poonawalla said that the company will be offering a compensation of Rs 25 lakh to each of the families of the deceased, in addition to the mandated amount as per the norms


Rashi Bisaria
New Delhi, January 21, 2021
A massive fire broke out at Terminal 1 gate of Serum Institute of India in Pune on Thursday afternoon. The blaze was reported at an under-construction building in the Manjri area of the city. The SII plant is spread over 100 acres in Pune. Visuals showed large plumes of smoke billowing out of the buildings. As per initial reports, eight fire tenders were rushed to the fire spot.


BusinessToday.In
January 21, 2021
SII CEO Adar Poonawalla reassured that there would be no loss of Covishield production due to multiple production buildings that had been kept in reserve to deal with such contingencies


BusinessToday.In
January 19, 2021
The Serum Institute of India (SII) said one should not get the jab's shot if he/she had a severe allegoric reaction following a previous dose of Covishield


BusinessToday.In
January 12, 2021
Coronavirus vaccination: We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request that we want to support the common man, vulnerable, poor and healthcare workers, said Poonawalla


BusinessToday.In
January 7, 2021
COVID-19 vaccination drive: This development comes after the government said that the vaccine would be rolled out 10 days after the date of approval for emergency use


Joe C Mathew
January 5, 2021
The statement came shortly after Adar Poonawala, CEO, Serum Institute tweeted that a public statement would be issued to clear up any miscommunication between the two companies


BusinessToday.In
January 4, 2021
SII CEO Adar Poonawalla said that the company will start selling the Covishield to the Indian government and GAVI (Global Alliance for Vaccines and Immunisation) nations in the first stage, followed by the private market


BusinessToday.In
January 4, 2021
Both the vaccines got approval for emergency use authorisation on Sunday. They're both administered in two doses, the DCGI said in the permission letter


BusinessToday.In
January 4, 2021
The phase-2 trials of Zydus Cadila's coronavirus vaccine had been conducted in around 1,000 healthy adults


BusinessToday.In
January 3, 2021
Two leading vaccine contenders in India have been granted approval for restricted use in the country. Check out how netizens reacted to the news of the vaccines getting approved


BusinessToday.In
January 3, 2021
PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak


BusinessToday.In
January 2, 2021
Covishield DCGI approval: Pune-based Serum Institute will have to provide safety, efficacy and immunogenicity data from the ongoing clinical trials in India and globally


PAGES 1 OF 5  12345